Skip to main content
XRN logo

XRN · Chiron Real Estate Inc.

Track XRN — free
$25.70 -0.53 (-2.02%) At close · Nov 19
Market Cap
$340.44M
Shares
13.25M
Volume · Nov 19 188.59K Avg daily vol (3M) 149.56K

Price & Indicators

 

Key stats

Close
$25.70
Open
$26.02
Day range
$25.13–26.12
52-week closing range
$25.70–38.10
Average volume, 30 days
210K
Short interest
943K · 7.1% of shares · 3.7 days
Short volume, last session
49%
Last earnings
Nov 5, 2026
Latest filing
10-Q · Nov 6
Price history
Jan 2020 to Nov 2026

Up next

Feb 25, 2027 Est · unconfirmed · in 14 wks

Latest documents

2026
Nov 6
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Seniors housing acquisitions increased third-quarter revenue

Chiron Real Estate Inc. reported third-quarter revenue of $40.3 million, up $3.1 million from $37.2 million in 2025, primarily driven by resident fees and services from The Landing and The Riviera.

Revenue $40.34M ▲ 8.3% Net loss $5.74M Diluted EPS -$0.67
Read from the MD&A section
3 source passages
Chiron Real Estate Inc. has made a strategic decision to transition its business from a healthcare real estate company to a seniors housing REIT focused on operating communities through RIDEA-compliant structures. Total revenue for the three months ended September 30, 2026 was $40.3 million, compared to $37.2 million for the same period in 2025, representing an increase of $3.1 million. The increase was primarily driven by $6.2 million of resident fees and services of The Landing and The Riviera, as well as $1.5 million of growth within our existing portfolio. Open the document at this passage
Nov 5
Current report 8-K/A Events of Oct 1
Pinnacle acquisition completed for $173.2 million

Chiron Real Estate Inc. completed its $173.2 million acquisition of The Pinnacle North Bethesda on October 1, 2026. The community had 31% occupancy, 54 of 175 homes occupied, and a $1.5 million loss for the nine months ended October 1, 2026.

Completed an acquisition or sale of assets, Other events
3 source passages
On October 1, 2026, Chiron Real Estate Inc., through one or more subsidiaries, acquired The Pinnacle for $173.2 million per the agreement, and incurred acquisition costs of $5.0 million. The Pinnacle North Bethesda (the “Company” or “The Pinnacle”) is a newly constructed senior housing community located at 11555 Old Georgetown Road in North Bethesda, Maryland. The community opened and commenced lease-up in June 2026 and, as of October 1, 2026, consisted of 175 homes (88 independent living, 59 assisted living, and 28 memory care). As of October 1, 2026, 54 of the 175 homes were occupied, representing an occupancy rate of approximately 31%. Loss of $1.5 million for the nine months ended October 1, 2026 Open the document at this passage
Nov 5
Earnings call
Chiron shifts toward seniors housing amid outpatient portfolio sales

Chiron Real Estate Inc. reported core FFO of 75 cents per share and unit, closed over $430 million of proprietary seniors housing investments, and completed the 175-home Pinnacle acquisition, bringing its portfolio to 467 homes.

4 source passages
We've now closed over $430 million of proprietary seniors housing investments and built a fantastic team. During the third quarter, NAIRED defined FFO per share and unit was 50 cents, and our core FFO was 75 cents per share and unit. We're also excited to have completed the acquisition of the Pinnacle in October. The Pinnacle is a newly constructed 175-home community in North Bethesda. This investment brings our senior housing portfolio to three communities and 467 total homes. Open the document at this passage
Nov 4
Current report 8-K
Loss widens despite $173.2 million seniors housing acquisition

Chiron Real Estate Inc. reported a third-quarter net loss attributable to common stockholders of $8.9 million, or $0.67 per share, versus $6.0 million, or $0.45 per share, while expanding seniors housing through the $173.2 million acquisition of The Pinnacle.

Financial results Read from the first part of this long document
2 source passages
Reported quarterly net loss attributable to common stockholders of $8.9 million, or $0.67 per share, as compared to net loss of $6.0 million, or $0.45 per share, in the comparable prior year period. The Pinnacle: As previously disclosed, the Company completed the acquisition of The Pinnacle, a newly constructed, 175-home luxury seniors housing community located in North Bethesda, Maryland, in October 2026 for a purchase price of $173.2 million. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$156.54M
Trailing 12 months
Net income (TTM)
$62.05M
Trailing 12 months
Revenue growth YoY
+8.3%
Year over year
Operating margin
—
Trailing 12 months
P / FFO
7.1×
Company-stated · TTM · reciprocal yield 14.1%
P / E (TTM)
7.4
Trailing earnings · reciprocal yield 13.6%
Return on invested capital
—
Trailing 12 months
Net cash
−$648.26M
Latest balance sheet
Dividend yield
9.6%
Trailing 12 months
Shares change YoY
-1.1%
Year over year · fewer shares
Price change (1Y)
-18.2%
Trailing year
Short interest
7.1%
Latest settlement · 3.7 days to cover
View all 129 metrics

AI Brief

Q3 FY26 earnings call · Nov 5, 2026
Q3 FY26

TL;DR. Chiron expanded its seniors housing platform through The Pinnacle, recorded sequential occupancy gains at The Landing, The Riviera, and The Pinnacle, and delivered 1.6% year-over-year outpatient medical same-property Cash NOI growth. Third-quarter earnings declined, leverage increased, G&A included transition expenses, and outpatient medical leasing and margins weakened.

Bullish
  • + Chiron acquired The Pinnacle and expanded its seniors housing portfolio to three communities and 467 homes.
  • + Riviera's leading indicators improved, including a 20% sequential increase in lead generation.
  • + Chiron is encouraged by investor interest in the outpatient medical portfolio disposition process.
  • + Outpatient medical same-property Cash NOI grew 1.6% year over year, in line with management expectations.
Bearish
  • − Third-quarter net loss attributable to common stockholders widened from the comparable prior-year period.
  • − Per-share FFO and Core FFO declined year over year.
  • − Third-quarter G&A included $2.0 million of severance and transition expenses associated with the seniors housing pivot.
  • − Chiron agreed to a $2.6 million White Rock lease cure amount payable over time.
  • − Leverage increased to 41.2% from 39.9% at quarter end.
  • − Outpatient medical leasing and margins weakened, with lower sequential occupancy and net absorption, higher operating costs, and a lower NOI margin.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol High
Market backdrop VIX 28.4 · fear Equity put/call 0.72
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −26%
below
Price vs 50-day avg −19%
below
RSI (14) 30
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −15%
trailing
6-month return −27%
trailing
YTD return −24%
this year
Relative strength −21%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $32 › 200d $35 — 200d above 50d
Institutional flow Accumulating
+3% holders QoQ · +24 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
7.12% of shares out · ▲ +1.1% MoM · 3.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
175 holders — near 1-yr high, broad support
Squeeze score 63
elevated · 0–100
Fundamentals
Strong
Revenue growth +7%
Y/Y
EPS growth −1617%
Y/Y
Free cash flow $41.8M
Buyback $44.0M
remaining
Balance sheet $7.9M
net cash
Quant / Vol
risk profile
High
Volatility 31%
annualized · 1-yr
Max drawdown −33%
past year
ATR 4.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 5, 2026
Yield on cost · during the second half of 2028 at least 7%
Previous outlook earlier release · from the 8-K filed Nov 4, 2026

Still-open targets the latest release did not restate under the same label.

Yield-on-cost · the second half of 2028 at least 7%
Yield-on-cost · 2029 at least 7%
Cash Yield · upon stabilization 7% – 7.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−26% Bearish
Price vs 50-day avg
−19% Bearish
RSI (14)
30 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $32 › 200d $35 — 200d above 50d
Institutional flow Accumulating
+3% holders QoQ · +24 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
7.12% of shares out · ▲ +1.1% MoM · 3.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
175 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $26 Now $26 · 0% Range high $38
vs 200-day avg -26% vs 50-day avg -19%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDAre non-GAAP $26.12M Three Months Ended June 30, 2026 filing —
Cash NOI non-GAAP $30.09M Three Months Ended June 30, 2026 filing —
Core FFO attributable to common stockholders and noncontrolling interest non-GAAP 15.1M Three Months Ended June 30, 2026 filing —
EBITDAre non-GAAP 24.59M Three Months Ended June 30, 2026 filing —
FAD attributable to common stockholders and noncontrolling interest non-GAAP 11.7M Three Months Ended June 30, 2026 filing —
FFO attributable to common stockholders and noncontrolling interest non-GAAP 12.74M Three Months Ended June 30, 2026 filing —
NOI non-GAAP $29.82M Three Months Ended June 30, 2026 filing —
Same-Property Cash NOI non-GAAP $24.11M Three Months Ended June 30, 2026 filing —
SHOP Segment NOI $0.3M the three months ended June 30, 2026 filing —
annualized Cash NOI non-GAAP $100M Q2 2026 —
Cash NOI (Annualized) non-GAAP $120.3M Home —
Core FFO attributable to common stockholders and noncontrolling interest per share and unit non-GAAP $1.04 Q2 2026 —
FFO attributable to common stockholders and noncontrolling interest per share and unit non-GAAP $0.88 Q2 2026 —
leasable square feet 4.6M Q2 2026 —
leased occupancy rate 95% Q2 2026 —
Leased Rate 94.7% 2Q 2026 —
OM Square Feet 4.6M Home —
Property Count 184 Home —
Same-Property Cash NOI Growth (Year-Over-Year) non-GAAP 0.8% 2Q 2026 —
SHOP Homes 292 Home —
The Landing occupancy 93% Q2 2026 —
The Riviera occupancy 23% Q2 2026 —
WALT 4.4 Q2 2026 —
Weighted average annual base rent escalations 2.1% Q2 2026 —
Weighted Average LTIP Units 806K Three Months Ended June 30, 2026 —
weighted average remaining term 3.6 Q2 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

REIT - Healthcare Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
XRN
Chiron Real Estate Inc.
this stock
$340.44M -23.8% +6.8% — 7.1%
WELL
Welltower Inc.
$178.41B +31.0% +35.6% 105.7 2.4%
VTR
Ventas, Inc.
$46.01B +12.4% +18.5% 164.2 2.8%
OHI
Omega Healthcare Investors Inc
$13.97B +3.6% +13.2% 18.4 4.8%
AHR
American Healthcare REIT, Inc.
$13.37B +22.4% +9.1% 115.2 14.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
175
% held
77.7%
Net QoQ
+338.2K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
140
View
Short & Settlement
Short Interest Rising
Shares short
942.6K
Days to cover
3.7d
Change
+10.6K sh
View
Short Volume
Short vol %
49%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
290
Value
$8.9K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
40.1%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Thomas R Carper
Amount
$1.0K–$15.0K
Traded
Oct 17, 2022
View
Financials
Financials
Revenue (FY)
$148.2M
Net income (FY)
$-6.9M
EPS diluted
$-0.91
View
Buybacks
Authorized
$50.0M
Remaining
$44.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 6, 2026
This year
25

Chiron Real Estate Inc. reported third-quarter revenue of $40.3 million, up $3.1 million from $37.2 million in 2025, primarily driven by resident fees and services from The Landing and The Riviera.

View
Proposed Sales
Value
$878.0K
Shares
130.0K
Filed
Aug 15, 2025
View
Exempt Offerings
Offering
$100.0M
Filed
Jun 15, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Chiron Real Estate Inc. Announces…
Published
Nov 4, 2026
View

Performance

5D 20D 120D MTD YTD
XRN -3.3% -14.8% -27.0% -15.4% -23.8%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY +2.1% -8.5% -21.3% -10.1% -28.8%

Capital returns

Latest dividend
$0.16 / share · ex Nov 20, 2026
Cut 36%
Paid (TTM)
$2.46 / share · 10 payouts
Dividend yield (TTM, derived)
9.57%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$50.00M
Spent (derived)
$6.00M
Remaining
$44.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1533615 CUSIP 37954A303 13F (30d) 164 filings 157 filers Visit website Investor relations